|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
By Industry | By Industry Segment | By Services and Suppliers
| By Location
| By Hotbed |
Profile Search
|
King Pharmaceuticals, Inc. - Sterile Products Operations
870 Parkdale Road
Rochester
Michigan
48307
U.S.A.
Phone:
248-651-9081
Fax:
|
King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that manufactures, markets and sells primarily branded prescription pharmaceutical products for a variety of pharmaceutical and biotechnology companies.
With 90 employees, in January 1994 King Pharmaceuticals opened the doors of its 450,000 square foot facility in Bristol, Tennessee, as a contract manufacturer of prescription medicines for other leading pharmaceutical companies. Soon after, the company adopted its present strategy of selectively acquiring branded prescription pharmaceutical products being divested. Gaining recognition throughout the pharmaceutical industry as a trustworthy and innovative leader, the company has established a strong record of growth through strategic purchases of well-known pharmaceuticals, effective marketing of our products, and product life-cycle management.
Today, King employs approximately 1,900 people involved in all disciplines of a major pharmaceutical enterprise, including scientific development, regulatory, medical affairs, quality assurance/quality control, product development, manufacturing, and sales and marketing. It operates five manufacturing facilities that produce a broad array of dosage forms including tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments, injectibles, and other drug products for human and animal health. The Company markets a variety of branded prescription products primarily over four therapeutic areas, including cardiovascular products, women's health products/endocrinology products, anti-infective products and critical care products.
In March 1998, King Pharmaceuticals established Parkedale Pharmaceuticals (now known as King Pharmaceuticals, Sterile Products Operations). The emphasis at this facility is on sterile manufacturing, and it employs approximately 450 associates. The Rochester, Michigan site manufactures sterile products for King, as well as clinical and commercial drugs for numerous pharmaceutical and biotechnology companies worldwide. Some of the products currently manufactured at this facility are Remicade (injection) for treatment of rheumatoid arthritis and Crohn's disease, Benadryl (injection) for treatment of hay fever and allergies, and Nutropin (injection) a hormone used for children who do not make enough of this growth hormone on their own. This facility is also currently working together with Novavax on manufacturing HPV-16 VLP vaccines being evaluated by the National Cancer Institute in clinical trials. The vaccines are designed to prevent and/or treat HPV-16 infection and associated cervical cancer.
Key Management:
John M. Gregory, Chairman
Last Updated: 06-07-02
Email:
Ownership:
Public
Web Site:
King Pharmaceuticals, Inc. - Sterile Products Operations
Employees:
1,900 Company wide (450 - Sterile Products Operations-Rochester, Michigan)
Symbol: KG
|
|
|
 |
|
|
|
|
|
|